Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain
Science Signaling · 2025
DOI: 10.1126/scisignal.adq4238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Hannah Gerninghaus und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Clinical Pharmacy, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Receptors, Atrial Natriuretic Factor, Signal Transduction, Nociceptors, Chronic Pain. Die Arbeit nennt 80 Literaturangaben.
Abstract (Originalsprache)
Natriuretic peptide receptor 2 (Npr2; also termed guanylyl cyclase B) is a transmembrane guanylyl cyclase that is highly abundant in nociceptors. Here, we investigated the role of production of cyclic GMP (cGMP) by Npr2 in pain processing. Adult mice with a deletion of Npr2 specifically in nociceptive sensory neurons exhibited deficits in noxious heat sensing, which can activate the nonselective cation channels TRPV1 and TRPA1. In parallel, Npr2-deficient mice showed a reduction in TRPV1-mediated nocifensive behavior and Ca 2+ influx into sensory neurons. Furthermore, Npr2-deficient mice had considerably reduced hypersensitivity after hindpaw injection of TRPA1 and TRPV1 activators or after hindpaw injection of complete Freund adjuvant, a model of persistent inflammatory pain. These results indicate that Npr2 contributes to the pain sensitization that can lead to chronic pain. Patch-clamp recordings revealed that the endogenous Npr2 ligand, C-type natriuretic peptide (CNP), enhanced the excitability of nociceptive sensory neurons through Npr2. CNP/Npr2 signaling led to the phosphorylation of cysteine-rich LIM-only protein 4 (CRP4), a substrate of cGMP-dependent protein kinase I. Behavioral and electrophysiological analyses using CRP4-deficient mice revealed that CRP4 limited CNP/Npr2-mediated pain sensitization. Our findings reveal a role for CNP/Npr2 signaling in sensory neurons in acute nociceptive and chronic pain and suggest that CRP4 is a downstream target that attenuates pain sensitization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology and Clinical Pharmacy, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
- Department of Anesthesiology and Intensive Care Medicine, Translational Pain Research, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50931 Cologne, Germany.
- Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany.
- Interfaculty Institute of Biochemistry, University of Tübingen, 72076 Tübingen, Germany.
ORCID-Profile: Hannah Gerninghaus, Jörg Isensee, Lea Kennel, Anja Kaiser, Tilman Gross, Patrick Engel, Christoph Jacobs, Jonas Petersen, Ruirui Lu, Robert Lukowski, Tim Hucho, Achim Schmidtko
Zitieren
APA
Gerninghaus, H., Isensee, J., Kennel, L., Zhou, F., Kaiser, A., Gross, T., Flauaus, C., Engel, P., Jacobs, C., Petersen, J., Kallenborn-Gerhardt, W., Lu, R., Metzner, K., Adler, J., Ruth, P., Lukowski, R., Hucho, T., Schmidt, H., & Schmidtko, A. (2025). Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain. Science Signaling. https://doi.org/10.1126/scisignal.adq4238
Vancouver
Gerninghaus H, Isensee J, Kennel L, Zhou F, Kaiser A, Gross T, et al. Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain. Science Signaling. 2025. doi:10.1126/scisignal.adq4238
BibTeX
@article{Gerninghaus2025,
author = {Gerninghaus, Hannah and Isensee, Jörg and Kennel, Lea and Zhou, Fangyuan and Kaiser, Anja and Gross, Tilman and Flauaus, Cathrin and Engel, Patrick and Jacobs, Christoph and Petersen, Jonas and Kallenborn-Gerhardt, Wiebke and Lu, Ruirui and Metzner, Katharina and Adler, Julia and Ruth, Peter and Lukowski, Robert and Hucho, Tim and Schmidt, Hannes and Schmidtko, Achim},
title = {Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adq4238}
}
EUVIMED